TY - JOUR
T1 - The effects of timolol on cataract extraction and intraocular pressure
AU - Obstbaum, Stephen A.
AU - Galin, Miles A.
N1 - Funding Information:
From the Department of Ophthalmology of the New York Medical College, New York, New York. This study was supported in part by a grant from Merck, Sharpe, and Dohme, West Point, Pennsylvania, and a grant from the Ophthalmological Foundation of America, Inc. (Dr. Galin). Reprint requests to Miles A. Galin, M.D., Ophthalmological Foundation of America, Inc., 113 E. 39th St., New York, NY 10016.
PY - 1979/12
Y1 - 1979/12
N2 - We studied the effect of timolol on postoperative intraocular pressures (IOPs) in a control and experimental group of 30 eyes, each in patients who had uncomplicated intracapsular cataract extractions, most with iris clip lenses. Closure of the eye in each case was with three 6-0 silk sutures preplaced in a morticed incision. Six control eyes had IOP increases of 6 mm Hg or more within 24 hours of surgery. One patient treated with timolol had an IOP increase of 6 mm Hg or more. The differences in IOP between the control and experimental groups were statistically significant at the .01 level. The pressure lowering ability of timolol appears to be prophylactic as well as therapeutic. It is well suited for pseudophakic eyes as pressure reduction is not associated with pupillary alterations.
AB - We studied the effect of timolol on postoperative intraocular pressures (IOPs) in a control and experimental group of 30 eyes, each in patients who had uncomplicated intracapsular cataract extractions, most with iris clip lenses. Closure of the eye in each case was with three 6-0 silk sutures preplaced in a morticed incision. Six control eyes had IOP increases of 6 mm Hg or more within 24 hours of surgery. One patient treated with timolol had an IOP increase of 6 mm Hg or more. The differences in IOP between the control and experimental groups were statistically significant at the .01 level. The pressure lowering ability of timolol appears to be prophylactic as well as therapeutic. It is well suited for pseudophakic eyes as pressure reduction is not associated with pupillary alterations.
UR - http://www.scopus.com/inward/record.url?scp=0018639148&partnerID=8YFLogxK
U2 - 10.1016/0002-9394(79)90408-2
DO - 10.1016/0002-9394(79)90408-2
M3 - Article
C2 - 517604
AN - SCOPUS:0018639148
SN - 0002-9394
VL - 88
SP - 1017
EP - 1019
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 6
ER -